All Stories

  1. Sporadic Alzheimer’s disease animal model using streptozotocin and APP/PS1 mice

    Article • January 2023, Elsevier

    Sally Kelliny

  2. Long term high fat diet induces metabolic disorders and aggravates behavioral disorders and cognitive deficits in MAPT P301L transgenic mice

    Article • Metabolic Brain Disease, June 2022, Springer Science + Business Media

    Sally Kelliny

  3. Preclinical validation of a novel oral Edaravone formulation for treatment of frontotemporal dementia

    Article • Neurotoxicity Research, October 2021, Springer Science + Business Media

    Sally Kelliny

  4. A New Approach to Model Sporadic Alzheimer’s Disease by Intracerebroventricular Streptozotocin Injection in APP/PS1 Mice

    Article • Molecular Neurobiology, April 2021, Springer Science + Business Media

    Sally Kelliny

  5. Pharmacokinetic Modelling of Human Recombinant Protein, p75ECD-Fc: A Novel Therapeutic Approach for Treatment of Alzheimer’s Disease, in Serum and Tissue of Sprague Dawley Rats

    Article • European Journal of Drug Metabolism and Pharmacokinetics, January 2021, Springer Science + Business Media

    Sally Kelliny

  6. Peripheral ProBDNF Delivered by an AAV Vector to the Muscle Triggers Depression-Like Behaviours in Mice

    Article • Neurotoxicity Research, July 2020, Springer Science + Business Media

    Sally Kelliny

  7. Preclinical Study of the Pharmacokinetics of p75ECD-Fc, a Novel Human Recombinant Protein for Treatment of Alzheimer’s Disease, in Sprague Dawley rats

    Article • Current Drug Metabolism, May 2020, Bentham Science Publishers

    Sally Kelliny